23 May 2013
Keywords: genentech, extends, stock, repurchase, plan, biotechnology, firm
Article | 01 May 2006
US biotechnology firm Genentech, which is majority-owned by Swiss drug major Roche, says that its board of directors has authorized ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 May 2006
22 May 2013
© 2013 thepharmaletter.com